Conavi Medical Corp.
CNVIF
$0.3238
-$0.0031-0.95%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.06% | 54.62% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.06% | 54.62% | -- | -- | -- |
| Cost of Revenue | -52.77% | -20.86% | -- | -- | -- |
| Gross Profit | 177.16% | 158.33% | -- | -- | -- |
| SG&A Expenses | -13.51% | 12.15% | -- | -- | -- |
| Depreciation & Amortization | -21.35% | -25.91% | -- | -- | -- |
| Other Operating Expenses | 22.43% | 22.43% | -- | -- | -- |
| Total Operating Expenses | -21.85% | 3.57% | -- | -- | -- |
| Operating Income | 29.41% | 3.61% | -- | -- | -- |
| Income Before Tax | 20.52% | -32.97% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.52% | -32.97% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.52% | -32.97% | -- | -- | -- |
| EBIT | 29.41% | 3.61% | -- | -- | -- |
| EBITDA | 29.49% | 2.63% | -- | -- | -- |
| EPS Basic | 49.40% | -8.49% | -- | -- | -- |
| Normalized Basic EPS | 63.01% | 22.54% | -- | -- | -- |
| EPS Diluted | 49.40% | -8.49% | -- | -- | -- |
| Normalized Diluted EPS | 63.01% | 22.54% | -- | -- | -- |
| Average Basic Shares Outstanding | 554.12% | 300.91% | -- | -- | -- |
| Average Diluted Shares Outstanding | 554.12% | 300.91% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |